AR059018A1 - Derivados de 6- fenil -1h- imidazo (4,5-c) piridina -4- carbonitrilo y su uso en el tratamiento de enfermedades relacionadas con catepsina s y/o catepsina k - Google Patents
Derivados de 6- fenil -1h- imidazo (4,5-c) piridina -4- carbonitrilo y su uso en el tratamiento de enfermedades relacionadas con catepsina s y/o catepsina kInfo
- Publication number
- AR059018A1 AR059018A1 ARP070100175A ARP070100175A AR059018A1 AR 059018 A1 AR059018 A1 AR 059018A1 AR P070100175 A ARP070100175 A AR P070100175A AR P070100175 A ARP070100175 A AR P070100175A AR 059018 A1 AR059018 A1 AR 059018A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- independently
- alkyloxy
- nitrogen
- attached
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 13
- 125000003545 alkoxy group Chemical group 0.000 abstract 6
- 125000005842 heteroatom Chemical group 0.000 abstract 6
- 229910052757 nitrogen Inorganic materials 0.000 abstract 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 6
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 6
- 229910052760 oxygen Inorganic materials 0.000 abstract 6
- 229910052717 sulfur Inorganic materials 0.000 abstract 6
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 5
- 125000000623 heterocyclic group Chemical group 0.000 abstract 5
- 229910052736 halogen Inorganic materials 0.000 abstract 4
- 150000002367 halogens Chemical class 0.000 abstract 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 125000003282 alkyl amino group Chemical group 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- PWCCDWCZFKPZBK-UHFFFAOYSA-N 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile Chemical class C=1C=2NC=NC=2C(C#N)=NC=1C1=CC=CC=C1 PWCCDWCZFKPZBK-UHFFFAOYSA-N 0.000 abstract 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 1
- 125000000041 C6-C10 aryl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000004043 oxo group Chemical group O=* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- -1 quinuclidin-3- yl Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- RAHZWNYVWXNFOC-UHFFFAOYSA-N sulfur dioxide Inorganic materials O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Reivindicacion 1: Un derivado de 6-fenil-1H-imidazo[4,5-c]piridina-4-carbonitrilo, caracterizado porque tiene la formula general (1), donde R es un orto- o meta-sustituyente opcional seleccionado entre halogeno y C1-4 alquiloxi; R1 es C1-4 alquilo, C1-4 alquiloxi, halogeno o CF3; R2 es C1-4 alquilo, C1-4 alquiloxi, o halogeno; R3 es H o (CH2)n-NR5R6; R4 es H o C1-6 alquilo, opcionalmente sustituido con COOR7 o NR8R9; R5 y R6 son independientemente H, C3-8 cicloalquilo, quinuclidin-3- ilo, C2-6 alquenilo o C1-6 alquilo, opcionalmente sustituido con halogeno, CF3, C3-8 cicloalquilo, C6-10 arilo, un grupo heteroarilo de 5 o 6 miembros, OH, C1-6 alquiloxi, C6-10 ariloxi, COOR10, CONR11R12, NR13R14 o NR13SO2(C1-4)alquilo; o R5 y R6, junto con el nitrogeno al cual están unidos, forman un anillo heterocíclico saturado de 4-8 miembros que opcionalmente comprende además 1 o más heteroátomos seleccionados entre O, S, SO2 y NR15, estando el anillo opcionalmente sustituido con oxo, C1-4 alquilo, C3-8 cicloalquilo, NR16R17 o CONR18R19; R7 es H o C1-4) alquilo; R8 y R9 son independientemente H, C1-4 alquilo (opcionalmente sustituido con di(C1-4)alquilamino) o C3-8 cicloalquilo; o R8 y R9 forman, junto con el nitrogeno al cual están unidos, un anillo heterocíclico saturado de 4-8 miembros que opcionalmente comprende además un heteroátomo seleccionado entre O y S; R10 es H o C1-4 alquilo; R11 y R12 son independientemente H o C1-4 alquilo; o R11 y R12, junto con el nitrogeno al cual están unidos, forman un anillo heterocíclico saturado de 4-8 miembros que opcionalmente comprende además un heteroátomo seleccionado entre O y S; R13 y R14 son independientemente H o C1-4 alquilo; o R13 y R14, junto con el nitrogeno al cual están unidos, forman un anillo heterocíclico saturado de 4-8 miembros que opcionalmente comprende además un heteroátomo seleccionado entre O y S; R15 es H, C1-4 alquilo (opcionalmente sustituido con OH, C1-4 alquiloxi, di(C1- 4)alquilamino o CONR21R22), fenilo, piridilo, COR20 o CONR21R22; R16 y R17 son independientemente H o C1-4 alquilo; o R16 y R17, junto con el nitrogeno al cual están unidos, forman un. anillo heterocíclico saturado de 4-8 miembros que opcionalmente comprende además un heteroátomo seleccionado entre O y S; R18 y R19 son independientemente H o C1-4 alquilo; R20 es H, C1-4 alquilo, C3-8 cicloalquilo, C1-4 alquiloxi o furilo; R21 y R22 son independientemente H o C1-4 alquilo; o R21 y R22, junto con el nitrogeno al cual están unidos, forman un anillo heterocíclico saturado de 4-8 miembros que opcionalmente comprende además un heteroátomo seleccionado entre O y S; y n es 0 o1; o una sal farmacéuticamente aceptable del mismo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06100357 | 2006-01-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR059018A1 true AR059018A1 (es) | 2008-03-05 |
Family
ID=35987201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070100175A AR059018A1 (es) | 2006-01-16 | 2007-01-16 | Derivados de 6- fenil -1h- imidazo (4,5-c) piridina -4- carbonitrilo y su uso en el tratamiento de enfermedades relacionadas con catepsina s y/o catepsina k |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1979351B1 (es) |
| JP (1) | JP5203968B2 (es) |
| KR (1) | KR20080098484A (es) |
| CN (1) | CN101374838B (es) |
| AR (1) | AR059018A1 (es) |
| AT (1) | ATE463496T1 (es) |
| AU (1) | AU2007204311B2 (es) |
| BR (1) | BRPI0706570A2 (es) |
| CA (1) | CA2635982A1 (es) |
| DE (1) | DE602007005775D1 (es) |
| EC (1) | ECSP088654A (es) |
| ES (1) | ES2342021T3 (es) |
| IL (1) | IL192133A0 (es) |
| NO (1) | NO20082791L (es) |
| NZ (1) | NZ569296A (es) |
| PE (1) | PE20080003A1 (es) |
| RU (1) | RU2400482C2 (es) |
| TW (1) | TW200734338A (es) |
| WO (1) | WO2007080191A1 (es) |
| ZA (1) | ZA200805566B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7932251B2 (en) | 2007-07-16 | 2011-04-26 | N.V. Organon | 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives |
| TW200911803A (en) * | 2007-07-16 | 2009-03-16 | Organon Nv | 6-phenyl-1H-imidazo [4,5-c] pyridine-4-carbonitrile derivatives |
| WO2010071819A1 (en) * | 2008-12-19 | 2010-06-24 | Schering Corporation | Bicyclic heterocyclic derivatives and methods of use thereof |
| TW201035094A (en) | 2009-01-16 | 2010-10-01 | Organon Nv | 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives |
| US8026236B2 (en) | 2009-01-16 | 2011-09-27 | N.V. Organon | 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives |
| PL2840083T3 (pl) * | 2012-04-17 | 2018-01-31 | Astellas Pharma Inc | Bicykliczny aromatyczny związek heterocykliczny zawierający azot |
| EP3623371A1 (en) | 2014-12-16 | 2020-03-18 | Axovant Sciences GmbH | Geminal substituted quinuclidine amide compounds as agonists of alpha-7 nicotinic acetylcholine receptors |
| MX2017016231A (es) | 2015-06-10 | 2018-11-29 | Axovant Sciences Gmbh | Compuestos de aminobencisoxazol como agonistas de receptores a7-nicotínicos de acetilcolina. |
| HK1253295A1 (zh) | 2015-08-12 | 2019-06-14 | Axovant Sciences Gmbh | 作为7-烟碱乙酰胆碱受体的激动剂的偕取代的氨基苯并异恶唑化合物 |
| AU2020250933A1 (en) | 2019-04-05 | 2021-10-28 | Centre Hospitalier Régional Et Universitaire De Brest | Protease-activated receptor-2 inhibitors for the treatment of sensory neuropathy induced by a marine neurotoxic poisoning |
| CN116514813A (zh) * | 2021-12-31 | 2023-08-01 | 轩竹生物科技股份有限公司 | 酪氨酸激酶抑制剂及其中间体的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU566842A1 (ru) * | 1976-01-06 | 1977-07-30 | Донецкое Отделение Физико-Органической Химии Института Физической Химии Им.Л.В.Писаржевского Ан Украинской Сср | Способ получени замещенных имидазопиридинов |
| UA62972C2 (en) * | 1997-07-03 | 2004-01-15 | Application of imidazopyrimidins and imidazopyridins for the treatment of neural disorders | |
| DE19845153A1 (de) * | 1998-10-01 | 2000-04-06 | Merck Patent Gmbh | Imidazo[4,5]-pyridin-4-on-derivate |
| SE0201980D0 (sv) * | 2002-06-24 | 2002-06-24 | Astrazeneca Ab | Novel compounds |
| US20070197510A1 (en) * | 2004-03-10 | 2007-08-23 | Kazuyuki Ohmoto | Nitriles and medicinal compositions containing the same as the active ingredient |
-
2007
- 2007-01-04 TW TW096100360A patent/TW200734338A/zh unknown
- 2007-01-15 EP EP07703872A patent/EP1979351B1/en active Active
- 2007-01-15 DE DE602007005775T patent/DE602007005775D1/de active Active
- 2007-01-15 AT AT07703872T patent/ATE463496T1/de not_active IP Right Cessation
- 2007-01-15 WO PCT/EP2007/050356 patent/WO2007080191A1/en not_active Ceased
- 2007-01-15 NZ NZ569296A patent/NZ569296A/en unknown
- 2007-01-15 PE PE2007000039A patent/PE20080003A1/es not_active Application Discontinuation
- 2007-01-15 BR BRPI0706570-1A patent/BRPI0706570A2/pt not_active IP Right Cessation
- 2007-01-15 AU AU2007204311A patent/AU2007204311B2/en not_active Ceased
- 2007-01-15 KR KR1020087016682A patent/KR20080098484A/ko not_active Withdrawn
- 2007-01-15 CN CN2007800031597A patent/CN101374838B/zh not_active Expired - Fee Related
- 2007-01-15 RU RU2008133588/04A patent/RU2400482C2/ru not_active IP Right Cessation
- 2007-01-15 JP JP2008549884A patent/JP5203968B2/ja not_active Expired - Fee Related
- 2007-01-15 CA CA002635982A patent/CA2635982A1/en not_active Abandoned
- 2007-01-15 ES ES07703872T patent/ES2342021T3/es active Active
- 2007-01-16 AR ARP070100175A patent/AR059018A1/es unknown
-
2008
- 2008-06-12 IL IL192133A patent/IL192133A0/en unknown
- 2008-06-20 NO NO20082791A patent/NO20082791L/no not_active Application Discontinuation
- 2008-06-25 ZA ZA200805566A patent/ZA200805566B/xx unknown
- 2008-07-30 EC EC2008008654A patent/ECSP088654A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ECSP088654A (es) | 2008-08-29 |
| CN101374838B (zh) | 2013-04-03 |
| JP2009523717A (ja) | 2009-06-25 |
| RU2400482C2 (ru) | 2010-09-27 |
| JP5203968B2 (ja) | 2013-06-05 |
| ZA200805566B (en) | 2009-04-29 |
| BRPI0706570A2 (pt) | 2011-04-05 |
| AU2007204311A8 (en) | 2008-07-31 |
| RU2008133588A (ru) | 2010-02-27 |
| CA2635982A1 (en) | 2007-07-19 |
| NO20082791L (no) | 2008-10-14 |
| EP1979351B1 (en) | 2010-04-07 |
| CN101374838A (zh) | 2009-02-25 |
| IL192133A0 (en) | 2008-12-29 |
| WO2007080191A1 (en) | 2007-07-19 |
| DE602007005775D1 (en) | 2010-05-20 |
| PE20080003A1 (es) | 2008-01-30 |
| ATE463496T1 (de) | 2010-04-15 |
| AU2007204311B2 (en) | 2011-07-14 |
| EP1979351A1 (en) | 2008-10-15 |
| TW200734338A (en) | 2007-09-16 |
| AU2007204311A1 (en) | 2007-07-19 |
| NZ569296A (en) | 2010-04-30 |
| KR20080098484A (ko) | 2008-11-10 |
| ES2342021T3 (es) | 2010-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR059018A1 (es) | Derivados de 6- fenil -1h- imidazo (4,5-c) piridina -4- carbonitrilo y su uso en el tratamiento de enfermedades relacionadas con catepsina s y/o catepsina k | |
| AR077505A1 (es) | Compuestos de piridina y sus usos | |
| AR052943A1 (es) | Derivados de 2-(4-oxo-4h-quinazolin-3-il)acetamida | |
| AR056536A1 (es) | Compuestos de 2-amino-5- [4-(difluormetoxi)fenil]-5-fenilimidazolona como inhibidores de la beta secretasa (bace) | |
| CO6150164A2 (es) | Derivados de 2-metilmorfolina pirido-,pirazo-ypirimido-pirimidina como inhibidores de mtor | |
| AR040047A1 (es) | 1-(aminoalquil)-3-sulfonilazaindoles como ligandos de la 5-hidroxitriptamina-6 | |
| AR060875A1 (es) | Derivados de 2-piridona como inhibidores de la neutrofilo elastasa humana | |
| AR064345A1 (es) | Derivados de 8-oxoadenina | |
| AR079164A1 (es) | Derivados heterociclicos de indol, composiciones farmaceuticas que los comprenden y uso de los mismos para la profilaxis o tratamiento de enfermedades alergicas, inflamatorias y/o autoinmunes. | |
| PE20141352A1 (es) | Fenil-3-aza-biciclo[3,1,0]hex-3-il-metanonas y su uso como medicamento | |
| AR087328A1 (es) | Derivados de imidazo[1,2-b]piridazina e imidazo[4,5-b]piridina como inhibidores de jak | |
| AR059338A1 (es) | N-fenilbenzotriazolilo como inhibidores de c-kit | |
| AR087288A1 (es) | Compuestos de tetrahidropirido-piridina y tetrahidropirido-pirimidina y su uso como moduladores de receptores de c5a | |
| AR065811A1 (es) | Derivados de 2-amino-4h-imidazol-4-ona,composiciones farmaceuticas que los contienen y usos para el tratamiento de la enfermedad de alzheimer y otros trastornos neurodegenerativos. | |
| AR065531A1 (es) | Derivados de pirimidina, procesos de obtencion y composiciones farmaceuticas. | |
| AR034203A1 (es) | Derivados de 1-aril- o 1-alquilsulfonilbenzazol como ligandos de 5-hidroxitriptamina-6, un metodo para su preparacion, composicion farmaceutica y el uso de los mismos para la fabricacion de un medicamento | |
| AR045595A1 (es) | Composiciones utiles como inhibidores de proteinas quinasas | |
| AR082633A1 (es) | Analogos de tetraciclina | |
| ES2605152T3 (es) | Derivados de pirazolquinolinona, su preparación y su uso terapéutico | |
| AR040230A1 (es) | Indol, azaindol, y heterociclos relacionados de 4-alquenil piperidina | |
| AR052458A1 (es) | Amino-imidazolonas para la inhibicion de beta-secretasa | |
| AR086546A1 (es) | Derivados de 7h-purin-8(9h)-ona como inhibidores de jak | |
| PE20110835A1 (es) | Piridiloxi-indoles inhibidores del vegf-r2 y uso de los mismos para el tratamiento de enfermedades | |
| AR053120A1 (es) | Aminopiridinas como inhibidores de beta secretasa | |
| AR073314A1 (es) | Derivados de indazol o de 4,5,6,7-tetrahidro-indazol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |